Stay updated on Dupilumab in Children With Asthma Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Children With Asthma Clinical Trial page.

Latest updates to the Dupilumab in Children With Asthma Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error page; its footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now presents a 403 Forbidden error, replacing the expected study content with a minimal error screen. This indicates access to the study record is blocked, while the site chrome remains visible.SummaryDifference19%

- Check33 days agoChange DetectedA new publication citation was added under Publications, referencing a 2026 J Allergy Clin Immunol article on dupilumab outcomes in pediatric asthma. This expands the study's bibliographic references without altering core study details.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded NIH grant/contract identifier: 2017 under Other Study ID Numbers. Updated page revision to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check68 days agoChange Detected500 error page is displayed with an HTML skeleton, indicating the study record content is temporarily unavailable. This reflects a site outage rather than an update to the study data.SummaryDifference17%

- Check83 days agoChange DetectedThe page revision has been updated from v3.6.3 to v3.6.4, indicating a newer version of the page. This is a metadata update with no impact on study details or results.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in Children With Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Children With Asthma Clinical Trial page.